High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy
Crossref DOI link: https://doi.org/10.1007/s00262-016-1810-0
Published Online: 2016-02-24
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kalathil, Suresh Gopi
Thanavala, Yasmin
Funding for this research was provided by:
National Cancer Institute (NCI) Core Grant to Roswell Park Cancer Institute (P30 CA016056-27)
Text and Data Mining valid from 2016-02-24